Actualités Aventis New Ads - AVE | Actions New York Stock Exchange

Rhone-Poulenc Overseas Limited Announces Redemption of All Outstanding Cumulative Guaranteed Preference Shares, Series A

Rhone-Poulenc Overseas Limited Announces Redemption of All Outstanding Cumulative Guaranteed Preference Shares, Series A NEW YORK, Oct. 15...

Aventis Ships 30 Million Doses of Influenza Vaccine to Health-Care Providers

Aventis Ships 30 Million Doses of Influenza Vaccine to Health-Care Providers Pre-Booked Customers Received Partial or Full Influenza Vaccine Order...

Advisory Panel Recommends FDA Licensure of Aventis' Menactra(TM) Vaccine for Protection Against Meningococcal Disease

Advisory Panel Recommends FDA Licensure of Aventis' Menactra(TM) Vaccine for Protection Against Meningococcal Disease - First Candidate...

Aventis Named to List of Top 100 Companies for Working Mothers

Aventis Named to List of Top 100 Companies for Working Mothers Receives Honors Three Years Running BRIDGEWATER, N.J., Sept. 21...

The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity

The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity PARIS, Sept. 16 /PRNewswire-FirstCall/...

Coley Pharmaceutical Group Receives Payment From Aventis for Clinical Milestone in Collaboration on Allergic Respiratory Disease

Coley Pharmaceutical Group Receives Payment From Aventis for Clinical Milestone in Collaboration on Allergic Respiratory Diseases WELLESLEY...

FDA Approves Taxotere(R) for the Treatment of Women with Early Stage Breast Cancer

FDA Approves Taxotere(R) for the Treatment of Women with Early Stage Breast Cancer Earlier use of Taxotere(R) shown to significantly improve...

Aventis Submits Application for FDA Licensure of ADACEL(TM) Vaccine for Prevention of Tetanus, Diphtheria and Pertussis in Adole

Aventis Submits Application for FDA Licensure of ADACEL(TM) Vaccine for Prevention of Tetanus, Diphtheria and Pertussis in Adolescents...

Ventiv Health Announces Sales and Marketing Agreement with Aventis

Ventiv Health Announces Sales and Marketing Agreement with Aventis Contract Calls for Over 450 Sales Representatives Focused on Primary Care...

FDA Approves Sculptra(TM) (Injectable Poly-L-Lactic Acid)

FDA Approves Sculptra(TM) (Injectable Poly-L-Lactic Acid) BERWYN, Penn., Aug. 3 /PRNewswire/ -- Dermik Laboratories, the US dermatology arm of...

Aventis Reports Second-Quarter and First-Half Results for 2004

Aventis Reports Second-Quarter and First-Half Results for 2004 All figures refer to 2004 Group vs. 2003 Core unless otherwise stated STRASBOURG...

Aventis to Move Forward With Reissuance Process for Contested Lovenox Patent

Aventis to Move Forward With Reissuance Process for Contested Lovenox Patent BRIDGEWATER, N.J., July 27 /PRNewswire-FirstCall/ -- Aventis...

New Data Confirm Lovenox(R) is an Effective Antithrombotic for Treatment of Acute Coronary Syndromes

New Data Confirm Lovenox(R) is an Effective Antithrombotic for Treatment of Acute Coronary Syndromes SYNERGY, A to Z and a Systematic Overview of...

Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers

Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers PARIS, June 23 /PRNewswire-FirstCall/ -- On June 22, 2004, the Autorite...

Sanofi-Synthelabo's Offer for Aventis; Adjustment of Offer Terms on Approval of Aventis Dividend

Sanofi-Synthelabo's Offer for Aventis; Adjustment of Offer Terms on Approval of Aventis Dividend PARIS, June 14 /PRNewswire-FirstCall/...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Aventis New Ads (AVE)

Votre Hub pour des idées et discussions en direct en temps réel

AVE Actualités

Rhone-Poulenc Overseas Limited Announces Redemption of All Outstanding Cumulative Guaranteed Preference Shares, Series A

Aventis Ships 30 Million Doses of Influenza Vaccine to Health-Care Providers

Advisory Panel Recommends FDA Licensure of Aventis' Menactra(TM) Vaccine for Protection Against Meningococcal Disease

Aventis Named to List of Top 100 Companies for Working Mothers

The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity

Coley Pharmaceutical Group Receives Payment From Aventis for Clinical Milestone in Collaboration on Allergic Respiratory Disease

FDA Approves Taxotere(R) for the Treatment of Women with Early Stage Breast Cancer

Aventis Submits Application for FDA Licensure of ADACEL(TM) Vaccine for Prevention of Tetanus, Diphtheria and Pertussis in Adole

Ventiv Health Announces Sales and Marketing Agreement with Aventis

FDA Approves Sculptra(TM) (Injectable Poly-L-Lactic Acid)

Aventis Reports Second-Quarter and First-Half Results for 2004

Aventis to Move Forward With Reissuance Process for Contested Lovenox Patent

New Data Confirm Lovenox(R) is an Effective Antithrombotic for Treatment of Acute Coronary Syndromes

Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers

Sanofi-Synthelabo's Offer for Aventis; Adjustment of Offer Terms on Approval of Aventis Dividend

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Aventis New Ads (AVE) Actualités

Aventis New Ads (AVE)

Votre Hub pour des idées et discussions en direct en temps réel

AVE Actualités

Rhone-Poulenc Overseas Limited Announces Redemption of All Outstanding Cumulative Guaranteed Preference Shares, Series A

Aventis Ships 30 Million Doses of Influenza Vaccine to Health-Care Providers

Advisory Panel Recommends FDA Licensure of Aventis' Menactra(TM) Vaccine for Protection Against Meningococcal Disease

Aventis Named to List of Top 100 Companies for Working Mothers

The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity

Coley Pharmaceutical Group Receives Payment From Aventis for Clinical Milestone in Collaboration on Allergic Respiratory Disease

FDA Approves Taxotere(R) for the Treatment of Women with Early Stage Breast Cancer

Aventis Submits Application for FDA Licensure of ADACEL(TM) Vaccine for Prevention of Tetanus, Diphtheria and Pertussis in Adole

Ventiv Health Announces Sales and Marketing Agreement with Aventis

FDA Approves Sculptra(TM) (Injectable Poly-L-Lactic Acid)

Aventis Reports Second-Quarter and First-Half Results for 2004

Aventis to Move Forward With Reissuance Process for Contested Lovenox Patent

New Data Confirm Lovenox(R) is an Effective Antithrombotic for Treatment of Acute Coronary Syndromes

Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers

Sanofi-Synthelabo's Offer for Aventis; Adjustment of Offer Terms on Approval of Aventis Dividend

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités